Commercializing an injectable version of an intravenous drug for heart failure.
Industry: Health Care
First Day Return: +0.7%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 10/23/2017 |
Offer Price | $14.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 6.4 |
Deal Size ($mm) | $90 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 11/16/2017 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $90 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Burlington, MA, United States |
Founded | 2013 |
Employees at IPO | 28 |
Website www.scpharmaceuticals.com |